The Brighterside of News on MSN
New nanodrug is 20,000x more lethal to leukemia while sparing healthy cells
Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...
In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...
Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Phio Pharmaceuticals (($PHIO)) announced an update on their ongoing clinical study. Phio Pharmaceuticals is conducting a clinical study titled ...
While the benefits of screening tests for cervical cancer, breast cancer, and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening ...
The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback